FDA announced the release of 43 generic drug product-specific guidances, including 26 new guidances and 18 revised guidances. Ten of the new draft guidances and six of the revised guidances are for complex drug products, including multiple products that don’t yet have generic competition.
[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
